Table 1. The incidence and mortality of female genital cancers in China by cancer site and area, 2022.
| Area | Site | ICD-10 | Incidence | Mortality | |||||||
|
Cases
(×10,000) |
Ratio |
Crude rate
(1/10 5 ) |
ASIR
(1/10 5 ) |
Deaths
(×10,000) |
Ratio |
Crude rate (1/105) |
ASMR
(1/10 5 ) |
||||
| Note: Ratio means the proportion of the cases/deaths of the cancer site in the total cancer cases/deaths. Abbreviation: ASIR=age-standardized incidence rate; ASMR=age-standardized mortality rate. | |||||||||||
| All | All | C51–54, C56 | 29.63 | 12.94 | 42.89 | 26.90 | 10.49 | 11.10 | 15.18 | 8.44 | |
| Vulva | C51 | 0.41 | 0.18 | 0.60 | 0.32 | 0.20 | 0.21 | 0.28 | 0.14 | ||
| Vagina | C52 | 0.27 | 0.12 | 0.39 | 0.23 | 0.11 | 0.11 | 0.15 | 0.08 | ||
| Cervix | C53 | 15.07 | 6.58 | 21.81 | 13.83 | 5.57 | 5.89 | 8.06 | 4.54 | ||
| Corpus uteri | C54 | 7.77 | 3.39 | 11.25 | 6.84 | 1.35 | 1.43 | 1.96 | 1.05 | ||
| Ovary | C56 | 6.11 | 2.67 | 8.84 | 5.68 | 3.26 | 3.46 | 4.73 | 2.64 | ||
| Urban | All | C51–54, C56 | 17.84 | 12.43 | 39.38 | 25.94 | 5.98 | 11.54 | 13.20 | 8.05 | |
| Vulva | C51 | 0.23 | 0.16 | 0.51 | 0.30 | 0.11 | 0.21 | 0.24 | 0.13 | ||
| Vagina | C52 | 0.14 | 0.10 | 0.32 | 0.21 | 0.06 | 0.13 | 0.14 | 0.08 | ||
| Cervix | C53 | 8.55 | 5.96 | 18.87 | 12.49 | 3.02 | 5.82 | 6.66 | 4.11 | ||
| Corpus uteri | C54 | 5.01 | 3.49 | 11.06 | 7.10 | 0.79 | 1.52 | 1.74 | 1.03 | ||
| Ovary | C56 | 3.91 | 2.72 | 8.62 | 5.84 | 2.00 | 3.86 | 4.42 | 2.70 | ||
| Rural | All | C51–54, C56 | 11.78 | 13.77 | 49.60 | 28.73 | 4.50 | 10.57 | 18.98 | 9.04 | |
| Vulva | C51 | 0.18 | 0.21 | 0.76 | 0.36 | 0.09 | 0.21 | 0.37 | 0.15 | ||
| Vagina | C52 | 0.12 | 0.15 | 0.53 | 0.26 | 0.04 | 0.10 | 0.17 | 0.08 | ||
| Cervix | C53 | 6.52 | 7.61 | 27.42 | 16.23 | 2.55 | 5.98 | 10.74 | 5.16 | ||
| Corpus uteri | C54 | 2.76 | 3.23 | 11.63 | 6.45 | 0.56 | 1.32 | 2.38 | 1.07 | ||
| Ovary | C56 | 2.20 | 2.57 | 9.26 | 5.43 | 1.26 | 2.96 | 5.32 | 2.58 | ||